Northwest Biotherapeutics | NWBO - 営業経費





営業経費 変化する 日付
Agenus USD -199.08M 22.15M 2026-06
AstraZeneca USD 12.22B 4.04B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Celldex Therapeutics USD 714.56M 258.34M 2026-06
Eisai JPY 209.6B 6.14B 2026-06
Merck USD 15.77B 2.4B 2026-06
Northwest Biotherapeutics USD 11.39M 120.04M 2026-03
Pfizer USD 85.19B 4.91B 2026-06
Plus Therapeutics USD 8.15M 1.04M 2026-03
Roche Holding CHF 18.9B 2.12B 2026-06